FDA
-
-
-
-
-
-
-
Cytokinetics to Hold Annual Meeting of Stockholders
-
-
-
-
-
-
-
Cytokinetics reports positive phase 3 trial results for aficamten
-
-
-
-
-
-
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
-
-
-
-
-
-
Cytokinetics to Announce Fourth Quarter Results on February 24, 2026
-
-
-
-
-
-
-
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Gr
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $136 at H.C. Wainwright
-
-
-
-
-
-
-
Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Holley Inc. (NYSE: HLLY); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office
-
325,314 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

